NU51CK000360
Cooperative Agreement
Overview
Grant Description
Oregon application for epidemiology and laboratory capacity for prevention and control of emerging infectious diseases - the purpose of this funding is to protect the health and safety of the American people, and in particular people in Oregon, by enhancing the ability of Oregon Health Authority (OHA) and its partners to effectively prevent, detect, and respond to emerging infectious disease threats.
Through this application, OHA proposes to maintain capacity to improve infectious disease surveillance systems and outbreak response as well as provide training to local public health authorities (LPHAs) in these areas.
Secondly, we propose to improve laboratory capacity through continued collaboration with LPHAs to enhance the timely receipt of specimens, testing, and results reporting while maintaining core instrumentation to assure operational readiness and response.
Thirdly, we propose to maintain capacity to improve health information systems by advancing standards-based electronic data exchange, increasing information systems interoperability, and sustaining and enhancing integrated surveillance information systems.
Within this application, OHA proposes to augment our current capacity through the addition of projects enhancing genomic surveillance (Project D), wastewater surveillance (Project E), vaccine-preventable disease surveillance and response (Project J), gonorrhea surveillance (Project Q), and rabies surveillance (Project R).
Oregon will leverage this funding opportunity to build upon the enhancement achieved during the COVID-19 public health emergency while refocusing our attention on urgent communicable disease threats, including healthcare-associated infections such as Candida auris, antibiotic-resistant shigellosis clusters, and highly pathogenic avian influenza monitoring.
Through this application, OHA proposes to maintain capacity to improve infectious disease surveillance systems and outbreak response as well as provide training to local public health authorities (LPHAs) in these areas.
Secondly, we propose to improve laboratory capacity through continued collaboration with LPHAs to enhance the timely receipt of specimens, testing, and results reporting while maintaining core instrumentation to assure operational readiness and response.
Thirdly, we propose to maintain capacity to improve health information systems by advancing standards-based electronic data exchange, increasing information systems interoperability, and sustaining and enhancing integrated surveillance information systems.
Within this application, OHA proposes to augment our current capacity through the addition of projects enhancing genomic surveillance (Project D), wastewater surveillance (Project E), vaccine-preventable disease surveillance and response (Project J), gonorrhea surveillance (Project Q), and rabies surveillance (Project R).
Oregon will leverage this funding opportunity to build upon the enhancement achieved during the COVID-19 public health emergency while refocusing our attention on urgent communicable disease threats, including healthcare-associated infections such as Candida auris, antibiotic-resistant shigellosis clusters, and highly pathogenic avian influenza monitoring.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Oregon
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 202615% from $4,760 to $9,649,221.
Oregon Department Of Human Services was awarded
Oregon Enhanced Infectious Disease Prevention Grant
Cooperative Agreement NU51CK000360
worth $9,649,221
from National Center for Emerging and Zoonotic Infectious Diseases in August 2024 with work to be completed primarily in Oregon United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC).
The Cooperative Agreement was awarded through grant opportunity Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
8/1/24
Start Date
7/31/29
End Date
Funding Split
$9.6M
Federal Obligation
$0.0
Non-Federal Obligation
$9.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU51CK000360
Additional Detail
Award ID FAIN
NU51CK000360
SAI Number
NU51CK000360-675656957
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
HFJRBHKCBPR5
Awardee CAGE
1GVR0
Performance District
OR-90
Senators
Jeff Merkley
Ron Wyden
Ron Wyden
Modified: 9/24/25